PMA device
Advisa DR IPG, Advisa DR MRI IPG
Medtronic, Inc. · Pulse Generator, Permanent, Implantable (NVZ, Class III) · First FDA decision Apr 4, 2011, newest Nov 29, 2017Bradycardia and heart blockHeart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
0
Naming "Advisa DR IPG"
MAUDE reports
0
Brand "Advisa DR IPG", since 2015
PubMed studies
0
Mentioning "Advisa DR IPG"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Advisa DR IPG, Advisa DR MRI IPG
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- Advisa DR IPG, Advisa DR MRI IPGPMA supplement
P980035-S518 · Decided Nov 29, 2017 · 90 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- ADVISA DR IPG, AT501 DDDRP PACING SYSTEM IPGPMA supplement
P980035-S272 · Decided Mar 26, 2013 · 217 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
- ADVISA DR IPGPMA supplement
P980035-S264 · Decided Jun 4, 2012 · 89 days after receipt · Normal 180 Day Track
Device type: Pulse generator, permanent, implantable (NVZ) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Advisa DR IPG", any status and sponsor, newest update first.
No registered device study names "Advisa DR IPG".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Advisa DR IPG", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code NVZ
72,953 reports: 32,608 malfunction, 38,411 injury, 1,913 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2127-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
Z-2128-2025 · Started Jun 17, 2025 · Posted by FDA Jul 17, 2025
Reason given: A software update for Medtronic CareLink SmartSync Device Manager (SmartSync) is now available. The update eliminates the potential display of an erroneous electrical reset (pop-up) message upon interrogation with a SmartSync Device Manager. The erroneous message indicates an electrical reset has occurred. However, no...
Cause as FDA categorized it: Software design · Device type: Programmer, Pacemaker (KRG)
- Azure S DR MRI SureScan, Product number W3DR01Open, Classified
Z-1924-2025 · Started Apr 29, 2025 · Posted by FDA Jun 6, 2025
Reason given: Identified devices may experience sudden battery power failure without alarm, power supply power-on-resets, and interruption of therapy. Potential patient harms include insufficient pacing support leading to cardiac arrest, syncope, or hospitalization; or system revision (explant/replacement) leading to infection,...
Cause as FDA categorized it: Process change control · Device type: Pulse Generator, Permanent, Implantable (NVZ)
13 more recall records with a free account
Published research
The most relevant PubMed records for "Advisa DR IPG"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NVZ.
- CareLink Instruments & DDMA, CareLink SmartSync Common ApplicationMedtronic, Inc. · PMA 2023
- Affinity/Integrity/Victory/Zephyr/Accent Family of PacemakersAbbott Medical · PMA 2016
- Adapta, Versa, Sensia IPGEnPulse E1 IPG Kappa DR (Kappa 700/600)Medtronic, Inc. · PMA 2017
- Various Families of PacemakersMedtronic, Inc. · PMA 2008
- Cadence Family of IcdsAbbott Medical · PMA 2012
- Medtronic CareLink Monitor, CardioSight ReaderMedtronic, Inc. · PMA 2019
- Legend Plus Family of PacemakersMedtronic, Inc. · PMA 2011
- Advisa DR MRI SureScan Model A2DR01 IPG, Advisa SR MRI SureScan Model A3SR01 IPGMedtronic, Inc. · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.